-
1 Comment
Laboratory Corporation of America Holdings is currently in a long term uptrend where the price is trading 19.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Laboratory Corporation of America Holdings's total revenue rose by 52.0% to $4B since the same quarter in the previous year.
Its net income has increased by 313.2% to $938M since the same quarter in the previous year.
Finally, its free cash flow grew by 52.9% to $675M since the same quarter in the previous year.
Based on the above factors, Laboratory Corporation of America Holdings gets an overall score of 5/5.
Exchange | NYSE |
---|---|
CurrencyCode | USD |
ISIN | US5049221055 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Beta | 0.81 |
---|---|
Market Cap | 20B |
PE Ratio | 27.92 |
Target Price | 273.2839 |
Dividend Yield | 1.2% |
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025